Jeffrey Jerome Ludwig, Chief Commercial Officer at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 9,437 shares at $3.15 ($30K) on 2025-01-02, disclosed to the SEC on 2025-01-03.
Scheduled sale ($30k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2024-01-05 | $116K | — | Filing → |
| PBYI | SELL | 2023-07-06 | $40K | — | Filing → |
| PBYI | SELL | 2023-01-05 | $27K | — | Filing → |